Nasdaq

ReShape Lifesciences® Secures Patent for Innovative Vagal Neuromodulation Device to Treat Type 2 Diabetes with Enhanced Energy Efficiency

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
unr.edu

Bridging engineering and medicine

Josette El Zaklit is an associate professor in the department of Electrical & Biomedical Engineering. Her research focuses on studying the effects of high-intensity, nanosecond-duration electric ...
EurekAlert!

Research team progresses to final phase in NIH competition, expanding autonomic neuromodulation applications for spinal stimulation

East Hanover, NJ – March 21, 2024 – Marking significant progress towards improving the lives of individuals with spinal cord injuries, Kessler Foundation, University of Louisville, and John Hopkins ...
Frontiers

Advanced interventions for self-regulation and neuroplasticity

A variety of interventions have shown strong potential for enhancing self-regulation and fostering neuroplasticity. These ...
Nasdaq

BSX's Neuromodulation Arm Sees Growth: Q1 Highlights

Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s ...
KXAN

Research Team Progresses to Final Phase in NIH Competition, Pioneering Autonomic Neuromodulation to Expand Applications for Spinal Stimulation

Kessler Foundation, University of Louisville, and Johns Hopkins Applied Physics Lab (with the support of Medtronic), are one of the four teams to win Phase 2 of the Neuromod Prize, a competition ...